Puretech announces publication of new preclinical research from collaborators that supports mesenteric lymphatic dysfunction as a potential cause of and therapeutic target for obesity and insulin resistance

Boston--(business wire)--puretech health today announced the publication of a research paper in nature metabolism using its glyph technology platform.

PRTC Ratings Summary

PRTC Quant Ranking